DGAP-News: MPH MittelstÃ¤ndische Pharma Holding AG:

DGAP-News: MPH MittelstÃ¤ndische Pharma Holding AG / Key word(s):
Quarter Results/Development of Sales
MPH MittelstÃ¤ndische Pharma Holding AG: sustained growth

10.05.2012 / 17:36

---------------------------------------------------------------------

MPH MittelstÃ¤ndische Pharma Holding AG:

1st Quarter 2012: +15.7% Sales Growth; EBIT Margin 7.6%

In the first quarter of 2012, the MPH Group achieved a turnover of 40.66
million Euro (previous year: 35.14 million Euro) hence achieving an
increase of 15.7% in comparison to the same period of the previous year.
The earnings obtained before interest and tax (EBIT) were 3.09 million Euro
and reached a margin of 7.6%. The earnings obtained before amortisation;
interest and tax (EBITDA) were 3.19 million Euro and reached a margin of
7.87%.

The preliminary EBIT margin of the fiscal year 2011 was 7.3%.
In the first quarter of 2012, the MPH Group achieved a modest EBIT margin
increase to 7.6%.

The MPH Group does expect a stronger sales growth in the next quarters of
fiscal year 2012.

About the company MPH MittelstÃ¤ndische Pharma Holding AG:

The Berlin based company MPH MittelstÃ¤ndische Pharma Holding AG has
strategically concentrated its activities on growth segments in the
pharmaceutical market. With pharmaceutical products based on patent-free
and patent-protected active substances, which are made available through
the MPH group in the therapeutic areas oncology, HIV, rheumatology,
neurology and cardiovascular diseases, a contribution is made towards cost
reduction in the healthcare sector.

MPH MittelstÃ¤ndische Pharma Holding AG is listed in the Entry Standard
(Open Market) of the Frankfurt stock exchange

Key capital market data for MPH MittelstÃ¤ndische Pharma Holding AG:
Subscribed Capital: EUR 41.167.155
Stock exchange listed class of shares: Owner held-preferred shares
Number of circulating preference shares: 19.025.000
ISIN: DE000A0NF697
WKN: A0NF69
Stock Exchange code: 93MV

Contact:
MPH MittelstÃ¤ndische Pharma Holding AG
Patricia Blechinger 
Hubertusallee 73 
D-14193 Berlin

Tel.: +49 (0) 30 897 30 86 60 
Fax: +49 (0) 30 897 30 86 70 
Email: ir@mph-ag.de
Web: www.mph-ag.de                                                         


End of Corporate News

---------------------------------------------------------------------

10.05.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


169285 10.05.2012
DGAP-News: MPH MittelstÃ¤ndische Pharma Holding AG: sustained growth
